Prevalence and quantification of geographic atrophy associated with newly diagnosed and treatment-naïve exudative age-related macular degeneration

Autor: Sandrine Zweifel, Giuseppe Querques, Anne Sikorav, Camille Jung, Oudy Semoun, Eric H Souied, Mayer Srour
Přispěvatelé: Sikorav, A., Semoun, O., Zweifel, S., Jung, C., Srour, M., Querques, G., Souied, E. H., University of Zurich, Semoun, Oudy
Rok vydání: 2015
Předmět:
0301 basic medicine
10018 Ophthalmology Clinic
medicine.medical_specialty
Visual acuity
genetic structures
2804 Cellular and Molecular Neuroscience
Visual Acuity
610 Medicine & health
Fundus (eye)
Retina
03 medical and health sciences
Cellular and Molecular Neuroscience
chemistry.chemical_compound
2809 Sensory Systems
0302 clinical medicine
Atrophy
Ophthalmology
Geographic Atrophy
Prevalence
Medicine
Humans
Fluorescein Angiography
Aged
Retrospective Studies
Aged
80 and over

Neovascularisation
medicine.diagnostic_test
business.industry
Macula
Retrospective cohort study
Macular degeneration
Fluorescein angiography
medicine.disease
2731 Ophthalmology
eye diseases
Sensory Systems
Choroidal Neovascularization
Surgery
030104 developmental biology
Choroidal neovascularization
chemistry
030221 ophthalmology & optometry
sense organs
France
medicine.symptom
business
Indocyanine green
Tomography
Optical Coherence
Zdroj: The British journal of ophthalmology. 101(4)
ISSN: 1468-2079
Popis: Objective To identify and quantify geographic atrophy (GA) associated with neovascular age-related macular degeneration (AMD) at initial presentation using a fundus autofluorescence (FAF) semi-automated software and to correlate the results with demographic and clinical data. Design Retrospective, observational study. Methods The study population consisted of treatment-naive patients with newly diagnosed neovascular AMD. Best-corrected visual acuity, fundus photographs, infrared reflectance, FAF and spectral-domain optical coherence tomography were performed, associated with fluorescein and indocyanine green angiographies. Identification of GA was independently performed by three readers. Quantification of atrophy areas was done using RegionFinder Software (RFA), a semi-automated software embedded in Spectralis device (Heidelberg Engineering, Germany). Results We included 206 eyes of 173 consecutive patients (72% female, mean age: 79.7±9.1 years). Type I choroidal neovascularisation (CNV) was observed in 44.2% of eyes, type II CNV was observed in 20.9% and mixed CNV lesion was observed in 11.7%. Polypoidal choroidal vasculopathy was diagnosed in 7.7% and type III CNV was diagnosed in 15.5%. Analysis of FAF frames showed that GA was associated with nAMD in 46/206 eyes (22.3%). Taking into account data both from Region Finder and multimodal imaging, our results suggest that GA was present in 24.3% of eyes newly diagnosed with exudative AMD. Mean size of GA was 1.23±1.76 mm 2 (range 0.03–7.39). Conclusion GA is associated with nAMD in 1/4 of cases at initial presentation. Combined imaging, including RFA is an effective tool to identify and quantify GA at diagnosis.
Databáze: OpenAIRE